SSTR5 has the cytostatic effects of somatostatin in C6 glioma cells by activating PTPeta (protein tyrosine phosphatase eta) and inhibiting extracellular signal-regulated kinase (ERK)1/2 activity (56). This evidence concerns the gene MAPK3 and central nervous system cancer.